| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ATXS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2015 | George Jean | Director | Buy | 258,776 | $12.00 | $3,105,312.00 | -154.0% | |
| Jun 30, 2015 | Svlsf V, LLC | 10% Owner | Buy | 391,090 | $12.00 | $4,693,080.00 | -117.8% | |
| Jun 30, 2015 | Clarus Lifesciences Ii, L.P. | 10% Owner | Buy | 376,695 | $12.00 | $4,520,340.00 | +15.9% |